Apellis Pharmaceuticals, Inc.
CEO
17 appearances
Latest appearance 2026-01-12
Cedric Francois
CEO
Apellis Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Cedric Francois
Cedric Francois is recorded as CEO at Apellis Pharmaceuticals, Inc.. Apellis Pharmaceuticals, Inc. reported in an 8-K filed May 14, 2026 that Cedric Francois resigned as member of the Board of Directors of the Company and any committee thereof, effective May 14, 2026. The proxy statement of Apellis Pharmaceuticals, Inc. reports total compensation of $10,957,451 for Cedric Francois in fiscal 2024, including a base salary of $793,193. Disclosed compensation is on record for 8 fiscal years. Cedric Francois has spoken on 17 earnings calls across 1 company, most recently for Apellis Pharmaceuticals, Inc. on January 12, 2026.
“Effective as of the Effective Time, Mikael Dolsten, Paul Fonteyne, Stephanie Monaghan O’Brien, A. Sinclair Dunlop, Alec Machiels, Keli Walbert, Gerald Chan, Cedric Francois and Craig Wheeler each resigned from his or her respective position as a member of the Board of Directors of the Company and any committee thereof.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Apellis Pharmaceuticals, Inc.
CEO
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $793,193 | $10,957,451 |
| 2023 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $734,539 | $10,373,049 |
| 2022 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $680,827 | $9,203,556 |
| 2021 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $647,115 | $9,122,039 |
| 2020 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $618,769 | $9,275,425 |
| 2019 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $560,019 | $4,267,182 |
| 2018 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $550,000 | $4,074,540 |
| 2017 | Apellis Pharmaceuticals, Inc. | M.D., Ph.D. President & Chief Executive Officer | $400,000 | $1,662,972 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: member of the Board of Directors of the Company and any committee thereof
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q2 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q4 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q3 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q2 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q4 FY2023 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q3 FY2023 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q3 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
Show 6 earlier activities
-
Earnings call
Apellis Pharmaceuticals, Inc. Q2 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q1 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q4 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q3 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q2 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q1 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.